Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
20379 | 463 | 27.9 | 70% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
1 | 4 | ECONOMICS//EDUCATION & EDUCATIONAL RESEARCH//PSYCHOL | 3876184 |
110 | 3 | PSYCHIATRY//SCHIZOPHRENIA//BIPOLAR DISORDER | 71389 |
617 | 2 | ANTIPSYCHOTICS//CLOZAPINE//SCHIZOPHRENIA | 13940 |
20379 | 1 | AGRANULOCYTOSIS//CLOZAPINE//CLOZAPINE INDUCED AGRANULOCYTOSIS | 463 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | AGRANULOCYTOSIS | authKW | 1464638 | 19% | 26% | 86 |
2 | CLOZAPINE | authKW | 763851 | 38% | 7% | 175 |
3 | CLOZAPINE INDUCED AGRANULOCYTOSIS | authKW | 274790 | 1% | 83% | 5 |
4 | BLOOD DYSCRASIAS | authKW | 219820 | 2% | 33% | 10 |
5 | AGRANULOCYTOSIS INCIDENCE | authKW | 131900 | 0% | 100% | 2 |
6 | BLOOD MONITORING RECOMMENDATIONS | authKW | 131900 | 0% | 100% | 2 |
7 | CLOZAPINE RECHALLENGE | authKW | 131900 | 0% | 100% | 2 |
8 | NEUTROPENIA AGRANULOCYTOSIS | authKW | 131900 | 0% | 100% | 2 |
9 | NUCLEAR LOBE COUNT | authKW | 131900 | 0% | 100% | 2 |
10 | PYRIDOBENZAZEPINE | authKW | 131900 | 0% | 100% | 2 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Psychiatry | 12614 | 59% | 0% | 273 |
2 | Pharmacology & Pharmacy | 2080 | 40% | 0% | 184 |
3 | Psychology, Clinical | 364 | 7% | 0% | 31 |
4 | Psychology | 215 | 5% | 0% | 24 |
5 | Clinical Neurology | 196 | 10% | 0% | 48 |
6 | Toxicology | 172 | 6% | 0% | 30 |
7 | Neurosciences | 62 | 9% | 0% | 43 |
8 | Chemistry, Medicinal | 44 | 4% | 0% | 17 |
9 | Medicine, General & Internal | 32 | 6% | 0% | 26 |
10 | Hematology | 15 | 3% | 0% | 12 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ARCHIMEDES | 118708 | 1% | 60% | 3 |
2 | ABARBANEL PSYCHIAT HOSP | 65950 | 0% | 100% | 1 |
3 | ADHES GRP E ORATING THER EUTTARGET | 65950 | 0% | 100% | 1 |
4 | ADM NACL MEDICAMENTOS ALIMENTOS TECNOL | 65950 | 0% | 100% | 1 |
5 | ADULT TREATMENT PROGRAM | 65950 | 0% | 100% | 1 |
6 | ADV MOL DIAGNOST DIMA | 65950 | 0% | 100% | 1 |
7 | AMSTELVEEN | 65950 | 0% | 100% | 1 |
8 | BINGOL BRANCH | 65950 | 0% | 100% | 1 |
9 | CIRM B36 | 65950 | 0% | 100% | 1 |
10 | COMMUNITY REHABIL PSYCHIAT SERV | 65950 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY | 9179 | 3% | 1% | 16 |
2 | PHARMACOPSYCHIATRY | 8406 | 3% | 1% | 16 |
3 | JOURNAL OF CLINICAL PSYCHIATRY | 8358 | 6% | 0% | 30 |
4 | JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY | 7025 | 4% | 1% | 17 |
5 | AUSTRALASIAN PSYCHIATRY | 5757 | 2% | 1% | 9 |
6 | PSYCHOSOMATICS | 4032 | 3% | 0% | 13 |
7 | KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY | 2794 | 1% | 1% | 5 |
8 | ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE | 2306 | 2% | 0% | 9 |
9 | PSYCHOPHARMAKOTHERAPIE | 2115 | 1% | 1% | 4 |
10 | WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY | 2109 | 1% | 1% | 5 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | AGRANULOCYTOSIS | 1464638 | 19% | 26% | 86 | Search AGRANULOCYTOSIS | Search AGRANULOCYTOSIS |
2 | CLOZAPINE | 763851 | 38% | 7% | 175 | Search CLOZAPINE | Search CLOZAPINE |
3 | CLOZAPINE INDUCED AGRANULOCYTOSIS | 274790 | 1% | 83% | 5 | Search CLOZAPINE+INDUCED+AGRANULOCYTOSIS | Search CLOZAPINE+INDUCED+AGRANULOCYTOSIS |
4 | BLOOD DYSCRASIAS | 219820 | 2% | 33% | 10 | Search BLOOD+DYSCRASIAS | Search BLOOD+DYSCRASIAS |
5 | AGRANULOCYTOSIS INCIDENCE | 131900 | 0% | 100% | 2 | Search AGRANULOCYTOSIS+INCIDENCE | Search AGRANULOCYTOSIS+INCIDENCE |
6 | BLOOD MONITORING RECOMMENDATIONS | 131900 | 0% | 100% | 2 | Search BLOOD+MONITORING+RECOMMENDATIONS | Search BLOOD+MONITORING+RECOMMENDATIONS |
7 | CLOZAPINE RECHALLENGE | 131900 | 0% | 100% | 2 | Search CLOZAPINE+RECHALLENGE | Search CLOZAPINE+RECHALLENGE |
8 | NEUTROPENIA AGRANULOCYTOSIS | 131900 | 0% | 100% | 2 | Search NEUTROPENIA+AGRANULOCYTOSIS | Search NEUTROPENIA+AGRANULOCYTOSIS |
9 | NUCLEAR LOBE COUNT | 131900 | 0% | 100% | 2 | Search NUCLEAR+LOBE+COUNT | Search NUCLEAR+LOBE+COUNT |
10 | PYRIDOBENZAZEPINE | 131900 | 0% | 100% | 2 | Search PYRIDOBENZAZEPINE | Search PYRIDOBENZAZEPINE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | FLANAGAN, RJ , DUNK, L , (2008) HAEMATOLOGICAL TOXICITY OF DRUGS USED IN PSYCHIATRY.HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL. VOL. 23. ISSUE . P. 27 -41 | 51 | 70% | 64 |
2 | CURTO, M , GIRARDI, N , LIONETTO, L , CIAVARELLA, GM , FERRACUTI, S , BALDESSARINI, RJ , (2016) SYSTEMATIC REVIEW OF CLOZAPINE CARDIOTOXICITY.CURRENT PSYCHIATRY REPORTS. VOL. 18. ISSUE 7. P. - | 34 | 69% | 1 |
3 | ROGE, R , MOLLER, BK , ANDERSEN, CR , CORRELL, CU , NIELSEN, J , (2012) IMMUNOMODULATORY EFFECTS OF CLOZAPINE AND THEIR CLINICAL IMPLICATIONS: WHAT HAVE WE LEARNED SO FAR?.SCHIZOPHRENIA RESEARCH. VOL. 140. ISSUE 1-3. P. 204-213 | 45 | 47% | 32 |
4 | RONALDSON, KJ , FITZGERALD, PB , MCNEIL, JJ , (2015) CLOZAPINE-INDUCED MYOCARDITIS, A WIDELY OVERLOOKED ADVERSE REACTION.ACTA PSYCHIATRICA SCANDINAVICA. VOL. 132. ISSUE 4. P. 231 -240 | 28 | 65% | 14 |
5 | COSAR, B , TANER, ME , ESER, HY , ALTINOZ, AE , TARHAN, R , (2011) DOES SWITCHING TO ANOTHER ANTIPSYCHOTIC IN PATIENTS WITH CLOZAPINE-ASSOCIATED GRANULOCYTOPENIA SOLVE THE PROBLEM? CASE SERIES OF 18 PATIENTS.JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY. VOL. 31. ISSUE 2. P. 169 -173 | 26 | 93% | 6 |
6 | ABANMY, NO , AL-JALOUD, A , AL-JABR, A , AL-RUWAISAN, R , AL-SAEED, W , FATANI, S , (2014) CLOZAPINE-INDUCED BLOOD DYSCRASIAS IN SAUDI ARAB PATIENTS.INTERNATIONAL JOURNAL OF CLINICAL PHARMACY. VOL. 36. ISSUE 4. P. 815 -820 | 27 | 79% | 2 |
7 | SINGH, A , GROVER, S , MALHOTRA, P , VARMA, SC , (2016) LATE ONSET AGRANULOCYTOSIS WITH CLOZAPINE ASSOCIATED WITH HLADR4 RESPONDING TO TREATMENT WITH GRANULOCYTE COLONY-STIMULATING FACTOR: A CASE REPORT AND REVIEW OF LITERATURE.CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE. VOL. 14. ISSUE 2. P. 212 -217 | 21 | 88% | 1 |
8 | SIMON, L , CAZARD, F , (2016) CLOZAPINE RECHALLENGE AFTER NEUTROPENIA IN RESISTANT SCHIZOPHRENIA: A REVIEW.ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE. VOL. 42. ISSUE 4. P. 346 -353 | 21 | 88% | 0 |
9 | HUGUET, G , LILLO-LE LOUET, A , DARNIGE, L , LOO, H , KREBS, MO , (2013) CLOZAPINE RECHALLENGE IN RESISTANT SCHIZOPHRENIA DISORDER AFFECTING "SUPER SENSITIVE" PATIENTS, AFTER NEUTROPENIA UNDER CLOZAPINE: A CASE REPORT.ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE. VOL. 39. ISSUE . P. S42-S48 | 21 | 84% | 1 |
10 | STIP, E , LANGLOIS, R , THUOT, C , MANCINI-MARIE, A , (2007) FATAL AGRANULOCYTOSIS: THE USE OF OLANZAPINE IN A PATIENT WITH SCHIZOPHRENIA AND MYELODYSPLASIA.PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY. VOL. 31. ISSUE 1. P. 297-300 | 18 | 100% | 6 |
Classes with closest relation at Level 1 |